Grødeland G, Baranowska Hustad M, Abadejos J, Blane T, Teijaro J, Nemazee D, et al. Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin. Front Immunol. 2020;11:431 pubmed publisher

Martínez D, Múnera M, Cantillo J, Wortmann J, Zakzuk J, Keller W, et al. An Engineered Hybrid Protein from Dermatophagoides pteronyssinus Allergens Shows Hypoallergenicity. Int J Mol Sci. 2019;20: pubmed publisher

Andersen T, Huszthy P, Gopalakrishnan R, Jacobsen J, Fauskanger M, Tveita A, et al. Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules. NPJ Vaccines. 2019;4:9 pubmed publisher

Martínez Calle N, Pascual M, Ordoñez R, San Jose Eneriz E, Kulis M, Miranda E, et al. Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene epigenetically regulated. Haematologica. 2019;: pubmed publisher

Andersen T, Zhou F, Cox R, Bogen B, Grødeland G. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza. J Virol. 2017;91: pubmed publisher

Arutla V, Leal J, Liu X, Sokalingam S, Raleigh M, Adaralegbe A, et al. Prescreening of Nicotine Hapten Linkers in Vitro To Select Hapten-Conjugate Vaccine Candidates for Pharmacokinetic Evaluation in Vivo. ACS Comb Sci. 2017;19:286-298 pubmed publisher